NVAX 8-K 2026-10-29

NOVAVAX INC (NVAX) 8-K dated 2026-10-29 — accession 0001104659-26-120221.

NOVAVAX INC (NVAX) is a biotechnology company listed on US.

NOVAVAX INC filed a 8-K on 2026-10-29. Accession 0001104659-26-120221.

This 8-K covers: Reg FD disclosure (Item 7.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported NVAX revenue for 2025-12-31 was $1.12B. Net income was $440.3M. Revenue was up 64.7% from 2024-12-31 to 2025-12-31. NVAX currently screens at market cap $1.09B.

Not investment advice. The NVAX SEC hub lists recent forms. The stock page is the research view.